News/SEC filing/Feb 4, 2026, 9:23 AM ET

Novo Nordisk files annual report (20-F) for the period ended Dec 31, 2025

Novo NordiskNVO

Novo Nordisk filed its annual report on Form 20-F with the SEC on Feb 4, 2026, 9:23 AM ET, covering the fiscal year ended Dec 31, 2025.

  • Fiscal 2025 revenue: $309.06B
  • Fiscal 2025 diluted EPS: $23.03
  • Form 20-F accepted by EDGAR Feb 4, 2026, 9:23 AM ET
  • Accession number 0000353278-26-000012
Source
SEC EDGAR
Feb 4, 2026, 9:23 AM ET
Read the original ↗

SEC filing 20-F · accession 0000353278-26-000012 · sec.gov ↗